Introducing the pVasc Thrombectomy System
Vesalio is excited to announce the launch of the pVasc™ mechanical thrombectomy system. This device is designed for the safe and effective non-surgical removal of blockages in the peripheral vasculature. The pVasc system aims to provide healthcare professionals with a dependable solution for treating patients who suffer from conditions like acute limb ischemia (ALI) and various types of peripheral artery disease (PAD).
Exploring the Technology
The pVasc system is distinguished by its advanced Drop Zone™ technology, which effectively traps, retains, and removes thrombus. This innovative mechanism facilitates the quick restoration of blood flow, offering significant benefits to individuals facing acute occlusions. Additionally, the flexibility of the pVasc system allows it to address a variety of embolisms, ranging from soft and acute clots to more difficult fibrin-rich and calcified formations.
Insights from Experts on pVasc
Dr. Frank Arko, a prominent vascular surgeon, shares his thoughts on the complex challenges that can arise when treating patients with ALI. He underscores the necessity of providing treatment in severely diseased arteries and narrow vessels. Thanks to its low profile and excellent deliverability, the pVasc system proves to be an essential tool for physicians during challenging cases, especially when operating below the knee.
Impact on Patients and Statistics
Peripheral artery disease (PAD) poses a serious health risk, affecting between 10 to 12 million adults in the U.S. who are over the age of 40. The severity of this condition elevates the risk of severe health consequences, including amputation, heart attack, stroke, and even death. Each year, approximately 185,000 amputations are reported in the U.S., with over 2 million individuals living with amputations. Alarmingly, the American Heart Association notes that nearly half of those aged 65 and older who undergo limb amputation due to PAD may tragically die within a year following surgery.
Clinical Experiences with pVasc
Dr. Nick Abedi, another esteemed vascular surgeon, reflects on the positive results he has achieved with the pVasc system. His experiences range from treating organized emboli in tibial arteries to managing complex cases in the brachial and distal ulnar arteries. Dr. Abedi emphasizes pVasc’s capability to eliminate the need for open surgery in many challenging scenarios, reinforcing its importance in clinical practice.
Device Specifications and Uses
The pVasc Thrombectomy System is specifically engineered for use in arteries with diameters ranging from 2 to 6 mm, typically found in the femoral-popliteal region, mesenteric area, upper extremities, and other targeted sites. Its self-expanding nitinol structure, mounted on a pusher wire, offers a versatile tool for physicians without requiring significant capital investments.
Vesalio's Commitment to Innovation
Steve Rybka, the CEO of Vesalio, reaffirms the company's commitment to enhancing vascular treatment options. He expresses enthusiasm about the positive feedback pVasc has garnered for its user-friendliness and effectiveness in managing difficult clots. Vesalio remains dedicated to developing innovative technologies that empower healthcare professionals to effectively address vascular occlusions.
About Vesalio
Founded in 2017, Vesalio is a pioneering medical device company dedicated to improving patient care in vascular diseases. The organization focuses on delivering superior technology that optimizes clinical outcomes. Its innovative platforms, including NeVa™, enVast™, and pVasc™, are specifically designed to tackle all types of clot removal, significantly aiding in the recovery of compromised ischemic tissue across various anatomical sites. Vesalio’s dedication has allowed its products to benefit over 12,000 patients worldwide.
Frequently Asked Questions
What is the pVasc Thrombectomy System?
The pVasc Thrombectomy System is a mechanical device designed for the non-surgical removal of peripheral occlusions, utilizing advanced Drop Zone™ technology for effective thrombus removal.
How does pVasc improve patient outcomes?
By providing a safe and effective means to restore blood flow, pVasc reduces the need for surgery and the associated risks, improving recovery times for patients with acute limb ischemia and peripheral artery disease.
What types of clots can pVasc target?
The device is effective against a range of clot types, including soft, acute clots, organized emboli, and more complex fibrin-rich or calcified clots.
Who are the key professionals involved with the pVasc system?
Notable vascular surgeons, including Dr. Frank Arko and Dr. Nick Abedi, provide expert insights on its efficacy and express satisfaction with the device's performance in clinical settings.
What is Vesalio's vision for the future?
Vesalio aims to continue innovating in the field of vascular treatment, ensuring that healthcare professionals have access to critical tools for improving patient care and outcomes.
